ASTRAZENECA PHARMA INDIA LTD. - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
26 Mar 2024
This is to inform that AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilized powder for concentrate for solution for infusion 100mg (Enhertu) from Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India for the attached additional indications.
Source:
BSE India